Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9359290 Treatment of cataplexy

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

June 7, 2016

Patent Application Number

14205423

Date Filed

March 12, 2014

Patent Citations Received

US Patent 12128021 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 12115144 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 12115165 Use of reboxetine to treat narcolepsy

0

US Patent 12115145 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

0

US Patent 11753368 Treatment of sleep-wake disorders

US Patent 11766418 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

US Patent 11779557 Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

US Patent 11839598 Methods of providing solriamfetol therapy to subjects with impaired renal function

0

...

Patent Primary Examiner

Raymond Henley, III

Patent abstract

The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9359290 Treatment of cataplexy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.